Treatment Registry
TR-1176 Not verifiedRecorded November 2026

Liraglutide

Recorded for Helimeds · every liraglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Provider website · Helimeds

Current availability of this program is not verified.

We earn nothing from this link. It opens Helimeds's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • November 2026 — Entry added to the register

Sourcing and terms

Pharmacydispensing pharmacy for liraglutide not disclosed. General terms name GoGoMeds as a partner; no individual liraglutide dispenser is established.
Statesliraglutide-specific eligible-state roster not disclosed. General service restrictions do not establish eligibility for this named clinical option.
Prescriberconsultation format for the liraglutide option not disclosed. The general consent describes asynchronous care; no liraglutide-specific pathway is established.
CancellationGeneral terms make received medical consultations nonrefundable and prescription sales final, subject to an applicable return or refund policy. The Compounded GLP-1 FAQ advertises no-fee cancellation, but no selected liraglutide plan, payment or program-specific refund conditions are established.
Membershipcare membership cost for a liraglutide plan not disclosed. The treatment-options answer names liraglutide without a matched plan or separate membership amount.
Consult feeconsultation charge applicable to a liraglutide prescription not disclosed. A general FAQ offers a complimentary consultation, but the selected liraglutide program and any ongoing consultation terms are not established.

Recorded from helimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. November 2026 — The treatment-options FAQ says the company’s treatment arsenal includes liraglutide. This identifies a named clinical option, but does not establish a brand, compounded or generic formulation, delivery route, device, price, selected supply or current individual fulfillment. https://www.helimeds.com/treatments/semaglutide
  2. 2. November 2026 — The same answer separately describes custom oral protocols using metformin, bupropion, topiramate, vitamin B12 and naltrexone. That list does not establish an oral GLP-1 or oral liraglutide product. The FAQ’s broad FDA-approved and clinical-benefit wording is not verification of a selected formulation or treatment outcome. https://www.helimeds.com/treatments/semaglutide
  3. 3. November 2026 — Travex operates the platform; general terms name Beluga Health and GoGoMeds, but do not assign an individual clinician or pharmacy to this liraglutide option. General cash-pay, state, fee and refund terms require confirmation for any selected plan. https://www.helimeds.com/terms-and-conditions
  4. 4. November 2026 — The how-it-works FAQ permits choosing a pharmacy outside the partner network, but says the patient then pays medication expenses. Advertised medication-inclusive program prices should not be assumed to cover that outside-pharmacy purchase. https://www.helimeds.com/how-it-works
  5. 5. November 2026 — The Compounded GLP-1 page advertises unlimited 24/7 communication access with a care team. The general telehealth consent expressly says personal data will not be monitored 24/7 and the service is not emergency care. Communication access is not continuous clinical monitoring or a guaranteed immediate response. https://www.helimeds.com/treatments/semaglutide https://www.helimeds.com/telehealth-consent

20 further notes concern other Helimeds programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1176
Medication category
liraglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Helimeds — liraglutide (TR-1176). Last verified November 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1176

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.